Eli Lilly shares surge after animal health IPO, earnings beat

FAN Editor

Shares of Eli Lilly surged nearly 7 percent Tuesday after the pharmaceutical company surpassed second-quarter estimates and announced it would file an initial public offering for its animal health unit public.

In the quarter, Eli Lilly reported a net loss of $259.9 million, or 25 cents per share. After stripping special items like charges related to business development transactions, Lilly earned $1.55 billion, or $1.50 per share, eclipsing estimates from analysts polled by Thomson Reuters of $1.30 per share.

In the year-ago quarter, Lilly’s net income was $1.01 billion, or 95 cents per share.

Lilly posted revenue of $6.36 billion, up 9 percent from the year-ago quarter and above estimates of $6.05 billion.

Investors welcomed Lilly’s decision to file an initial public offering for a less than 20 percent stake in its Elanco Animal Health unit. Following the offering, Lilly plans to divest its remaining ownership through a tax-efficient transaction. The unit’s sluggish sales had weighed on Lilly in previous quarters, prompting Lilly to perform a strategic review.

Lilly hiked its full-year adjusted earnings forecast to between $5.40 and $5.50 a share, up from the previous range of between $5.10 to $5.20.

Correction: Eli Lilly plans to take public a less than 20 percent stake in its Elanco Animal Health unit. An earlier version incorrectly stated the company would hold a minority stake in the unit after the IPO.

Free America Network Articles

Leave a Reply

Next Post

Some Goldfish recalled by Pepperidge Farm due to salmonella fears

NORWALK, Conn. — Pepperidge Farm is voluntarily recalling four varieties of Goldfish Crackers because of fears they could have salmonella. The company took the action Monday after one of its ingredient suppliers notified it that whey powder used in a seasoning may be contaminated.  The products were distributed in the […]